Skip to content

Author

Mariko Kogami

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Open access Aug 2026

Design Paper: The Short- and Long-term Effects of Inspiratory Muscle Training in Patients with Idiopathic Pulmonary Fibrosis—A Multicenter Randomized Controlled Trial (the Breathe IPF Trial)

Introduction: Pulmonary rehabilitation is beneficial for patients with idiopathic pulmonary fibrosis (IPF) but is often limited by poor adherence. Inspiratory muscle training (IMT) may represent a more feasible, home-based alternative. This trial aims to evaluate the short- (8-week) and long-term (56-week) effects of I...

Akihito Okada, H. Nakagawa, T. Handa et al. · 0 citations
Review Open access Sep 2026

Blood-based biomarkers associated with progressive pulmonary fibrosis in idiopathic inflammatory myositis-associated interstitial lung disease: A retrospective cohort study from a respiratory center

AISI and serum KL-6 may serve as accessible, non-invasive blood-based biomarkers associated with fibrotic progression in patients with IIM-ILD and showed the highest discriminative ability among the evaluated biomarkers.

M. Ishiwari, Yutaka Kono, Kenichi Kobayashi et al. · 0 citations
Open access Sep 2026

Mechanosensitive Stanniocalcin-1 Suppresses Smooth Muscle Cell Proliferation and Attenuates Experimental Pulmonary Hypertension

BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) is driven by progressive vascular remodeling, particularly smooth muscle cell (SMC) proliferation. Current combination vasodilator therapies have markedly improved outcomes; however, prognosis remains poor in subgroups such as patients with respiratory comor...

Mariko Kogami, Y. Kato, Satoko Ito et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.